Lamotrigine-Induced Neutropenia in a Woman With Schizoaffective Disorder

View This PDF

NB: This article is only available as a PDF.

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Lamotrigine is a drug of the phenyltriazine class with inhibitory effects on voltage-sensitive sodium channels along with modulating effects on calcium and potassium channels. Lamotrigine is also a weak dihydrofolate reductase inhibitor. The drug is currently approved by the U.S. Food and Drug Administration for maintenance treatment in bipolar type I disorder.​

Prim Care Companion J Clin Psychiatry 2007;9(6):471-472 [letter]

https://doi.org/10.4088/PCC.v09n0611i